Mar 01, 2017 21:01 pm UTC| Business
SEATTLE, March 01, 2017 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth...
Mar 01, 2017 21:01 pm UTC| Business
BURNABY, British Columbia, March 01, 2017 -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its 2016 financial and operating results after the...
Conifer Holdings Reports 2016 Fourth Quarter and Year End Financial Results
Mar 01, 2017 21:01 pm UTC| Business
BIRMINGHAM, Mich., March 01, 2017 -- Conifer Holdings, Inc. (Nasdaq:CNFR) (“Conifer” or the “Company”) today announced results for the fourth quarter and year ended December 31, 2016. Fourth Quarter 2016 Highlights...
Mar 01, 2017 21:01 pm UTC| Business
NEW YORK, March 01, 2017 -- KCAP Financial, Inc. (Nasdaq:KCAP) will release its financial results for the year ended December 31, 2016 on Wednesday, March 8, 2017 after the close of the markets. The company will host a...
Mar 01, 2017 21:01 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, March 01, 2017 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on cancer, today announced that it will report fourth quarter and year end 2016 financial...
Celldex Therapeutics Announces Appointment to Board of Directors
Mar 01, 2017 21:01 pm UTC| Business
HAMPTON, N.J., March 01, 2017 -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced the appointment of James J. Marino, J.D., to the Company’s Board of Directors. Mr. Marino was with the global law firm of Dechert...
Mar 01, 2017 21:01 pm UTC| Business
-- Plazomicin NDA submission planned for the second half of 2017 -- -- Plan to initiate clinical trial of orally-administered antibacterial candidate for ESBL+ infections, C-Scape, in 2017 -- -- Advances in research...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood